Rivermark Medical, a urology-focused medical device company committed to redefining benign prostatic hyperplasia (BPH) treatment through simple, innovative solutions, today announced the enrollment of ...

Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year ...

The bone graft incorporating rhBMP-2 has received FDA IDE approval for a pivotal clinical trial in spinal fusion ...

After reporting robust results, Resmed reckons it won't be subject to US tariffs while the growth of anti-obesity drugs will ...

Zai Lab Limited today announced that updated data from an ongoing, global Phase 1a/1b clinical trial (NCT06179069) evaluating ZL-1310, the Company's potential first-in-class and best-in-class, ...

There’s not a scam, crime, trick or fraud involving tourists or tourism venues with which he’s not expertly familiar, so when ...